The Post-Pandemic Supply Chain: Improving Resilience Via Value Chains

By Andrew Goldman, Head of Business Continuity Management, Lynn Stephenson, PhD., Senior Marketing Manager, Supply Security, and Oliver Prince, PhD., Senior Consultant, Strategy Optimization

The COVID-19 pandemic underscored the vulnerability of global supply chains, revealing the fragility of lean manufacturing techniques and ‘just-in-time’ inventory models. The strain of supply chain disruptions particularly impacted the pharmaceutical industry as it raced to eradicate the virus. Post-pandemic, supply chain resilience is top of mind. The industry is striving to fortify against future supply chain disruptions by developing a robust plan for the unexpected, involving stronger risk management and focus on the value of customers. The emphasis on value chains over supply chains, driven by customer-centric approaches, marks a transformative post-pandemic shift.

Strengthening the resilience of biopharmaceutical supply chains is not merely a business imperative, for patients around the world are relying on the timely delivery of life-changing and life-saving treatments. In this article, you will explore lessons learned from the pandemic, the concept of supply chain resilience, what to look for in a supplier, and much more.